" There can be only one." During a panel expert in Brussels of the ERVI (European Radioisotope Valley) Stakeholder Forum, our Head of Market & Supply, Nicolas Mario, highlighted the harsh competition among radionuclide manufacturing routes, until

✨ Just one month to go before EANM 2025 ! The MEDraysintell team is thrilled to confirm its renewed participation at this year's congress! Join us in Barcelona from October 4th to 8th, 2025, at booth 76A.

Driving Innovation in TRNT: MEDraysintell at the Heart of SoFRa 2025 💡 Great insights from the 14th Annual Meeting of the French Society of Radiopharmacy (Société Française de Radiopharmacie SoFRa) last Friday.Nicolas Mario, our Head of Market

Breaking Barriers in Cancer Treatment: A Nuclear Medicine Breakthrough The recent news of former U.S. President Joe Biden’s advanced prostate cancer diagnosis brings attention to the ongoing fight against cancer.Millions of people around the world are diagnosed

Securing Europe's Nuclear Medicine Supply Chain: A Call for Collaboration 📖 More than ever before, securing efficient and sustainable supply chains for medical radionuclides is crucial to uphold innovation in nuclear medicine. The MEDraysintell report highlights the

Back from RRFM 2025 – Exciting discussions around the future of medical isotope production ! 🎤 Back from RRFM 2025 – Exciting discussions around the future of medical isotope production !Nicolas Mario had the pleasure to present

France Biotech Event: Spotlight on Nuclear Medicine Innovation ✨Exciting News!Our Head of Medical & Science, Vincent Brechin, Ph.D., will participate tomorrow in a round table discussion organized by France Biotech on the theme: "Nuclear Medicine: Accelerating the

MEDraysintell acquired by NucAdvisor NucAdvisor is proud to announce the acquisition of MEDraysintell a brand with international experts providing first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy. MEDraysintell was created in 2013 by